Advertisement
Advertisement
U.S. Markets closed
S&P Futures
4,273.50 -7.50 (-0.18%) Dow Futures
33,661.00 -57.00 (-0.17%) Nasdaq Futures
13,553.25 -24.50 (-0.18%) Russell 2000 Futures
2,013.30 -3.60 (-0.18%) Crude Oil
91.69 -0.40 (-0.43%) Gold
1,816.10 +0.60 (+0.03%)
Amryt Pharma plc (AMYT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 7.84 |
| Open | 7.83 |
| Bid | 6.00 x 800 |
| Ask | 8.93 x 900 |
| Day's Range | 7.66 - 7.86 |
| 52 Week Range | 5.61 - 12.45 |
| Volume | |
| Avg. Volume | 76,679 |
| Market Cap | 489.956M |
| Beta (5Y Monthly) | 0.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Why Amryt Pharma (AMYT) Might Surprise This Earnings Season
Amryt Pharma (AMYT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
Amryt Pharma PLC Sponsored ADR (AMYT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Amryt Pharma PLC Sponsored ADR (AMYT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Amryt Pharma PLC Sponsored ADR (AMYT) Surges 5.5%: Is This an Indication of Further Gains?
Amryt Pharma PLC Sponsored ADR (AMYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
